Literature DB >> 3035489

Competition studies with repressors and activators of viral enhancer function in F9 mouse embryonal carcinoma cells.

M J Sleigh, T J Lockett, J Kelly, D Lewy.   

Abstract

DNA competition studies have been used to investigate the presence of a repressor of viral enhancer function in F9 mouse embryonal carcinoma cells. The complete polyoma virus enhancer region, cotransfected into F9 cells with the SV40 promoter/enhancer attached to a chloramphenicol acetyl transferase marker gene, induced a small increase in pSV2CAT expression. This can be explained by preferential but weak binding by polyoma sequences of a molecule repressing pSV2CAT transcription. Repressor activity substantially disappeared when the cells were induced to differentiate by retinoic acid. Repressor binding was localised to one half of the polyoma enhancer, but was lost on further fragmentation of this region. It appears that multiple sequence elements may be required for repressor binding and that these are at least partially separable from the complement of elements binding enhancer activating molecules.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035489      PMCID: PMC340849          DOI: 10.1093/nar/15.10.4307

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  37 in total

1.  Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells.

Authors:  M Wigler; S Silverstein; L S Lee; A Pellicer; Y c Cheng; R Axel
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

2.  Virus infection of murine teratocarcinoma stem cell lines.

Authors:  N M Teich; R A Weiss; G R Martin; D R Lowy
Journal:  Cell       Date:  1977-12       Impact factor: 41.582

3.  Susceptibility of teratocarcinoma cells to adenovirus type 2.

Authors:  F Kelly; M Boccara
Journal:  Nature       Date:  1976-07-29       Impact factor: 49.962

4.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid.

Authors:  S Strickland; V Mahdavi
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

5.  Alterations in the developmental potential of embryonal carcinoma cells in mixed aggregates of nullipotent and pluripotent cells.

Authors:  M J Rosenstraus; A J Levine
Journal:  Cell       Date:  1979-06       Impact factor: 41.582

6.  Polyoma virus infection of retinoic acid-induced differentiated teratocarcinoma cells.

Authors:  F K Fujimura; P E Silbert; W Eckhart; E Linney
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

7.  Delayed de novo methylation in teratocarcinoma suggests additional tissue-specific mechanisms for controlling gene expression.

Authors:  J W Gautsch; M C Wilson
Journal:  Nature       Date:  1983-01-06       Impact factor: 49.962

8.  Does the major histocompatibility complex serve as a specific receptor for Semliki Forest virus?

Authors:  M B Oldstone; A Tishon; F J Dutko; S I Kennedy; J J Holland; P W Lampert
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

9.  Resistance of teratocarcinoma stem cells to infection with simian virus 40: early events.

Authors:  D E Swartzendruber; T D Friedrich; J M Lehman
Journal:  J Cell Physiol       Date:  1977-10       Impact factor: 6.384

10.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

View more
  11 in total

1.  Negative regulation of the major histocompatibility complex class I promoter in embryonal carcinoma cells.

Authors:  J R Flanagan; M Murata; P A Burke; Y Shirayoshi; E Appella; P A Sharp; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

2.  The embryonal carcinoma stem cell Ela-like activity involves a differentiation-regulated transcription factor.

Authors:  N B La Thangue; B Thimmappaya; P W Rigby
Journal:  Nucleic Acids Res       Date:  1990-05-25       Impact factor: 16.971

3.  Defective expression of adenovirus genes during early infection of undifferentiated OTF963 embryonal carcinoma cells.

Authors:  C C Nelson; A W Braithwaite; M Silvestro; A J Bellett
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Negative and positive factors determine the activity of the polyoma virus enhancer alpha domain in undifferentiated and differentiated cell types.

Authors:  B Wasylyk; J L Imler; B Chatton; C Schatz; C Wasylyk
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  Differential regulation of viral and cellular genes in F9 mouse embryonal carcinoma cells.

Authors:  M J Sleigh
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

6.  Cell-specific activity of the constituent elements of the simian virus 40 enhancer.

Authors:  H Nomiyama; C Fromental; J H Xiao; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

7.  Inhibition of polyomavirus ori-dependent DNA replication by mSin3B.

Authors:  An-Yong Xie; William R Folk
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  The regulation of SV40 early gene expression in embryonal carcinoma stem cells--faithful transcriptional regulation in vitro.

Authors:  N B La Thangue; P W Rigby
Journal:  Nucleic Acids Res       Date:  1988-12-23       Impact factor: 16.971

Review 9.  Negative regulation of transcription in eukaryotes.

Authors:  A R Clark; K Docherty
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

10.  E1a-dependent expression of adenovirus genes in OTF963 embryonal carcinoma cells: role of E1a-induced differentiation.

Authors:  C C Nelson; A W Braithwaite; M Silvestro; A J Bellett
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.